Product Detail
Product NameH1N1 Hemagglutinin 2 Antibody FITC Conjugated
Host SpeciesRabbit
ClonalityPolyclonal
IsotypeIgG
PurificationPurified by Protein A.
Applications IF
Species ReactivityInfluenza A Virus H1N1
Immunogen DescKLH conjugated synthetic peptide aa 480-530 566 derived from Influenza A Virus Hemagglutinin (strain swl A California 04 2009 H1N1)
Target NameH1N1 Hemagglutinin 2
ConjugateFITC
Excitation Emission494nm 518nm
Other NamesHA; HA2; Hemagglutinin; Influenza A Virus (strain swl A California 04 2009 H1N1)
Accession NoSwiss-Prot#C3W5S1
Uniprot
C3W5S1
Concentration1mg ml
Formulation0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
StorageShipped at 4˚C. Store at -20˚C for one year. Avoid repeated freeze/thaw cycles.
Application Details
IF=1:50-200
Influenza A virus is a major public health threat. Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. HA interacts with cell surface proteins containing oligosaccharides with terminal sialyl residues. Binds to sialic acid-containing receptors on the cell surface, bringing about the attachment of the virus particle to the cell. This attachment induces virion internalization of about two third of the virus particles through clathrin-dependent endocytosis and about one third through a clathrin- and caveolin-independent pathway. Plays a major role in the determination of host range restriction and virulence. Class I viral fusion protein. Responsible for penetration of the virus into the cell cytoplasm by mediating the fusion of the membrane of the endocytosed virus particle with the endosomal membrane. Low pH in endosomes induces an irreversible conformational change in HA2, releasing the fusion hydrophobic peptide. Several trimers are required to form a competent fusion pore. Influenza A Virus (strain swl A California 04 2009 H1N1)
If you have published an article using product C03864F, please notify us so that we can cite your literature.